RCRirong Chen

Rirong Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rirong Chen has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Shenghong Zhang

    Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University, Nanning, China

    15 shared publications
  • Li Li

    Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    8 shared publications
  • Jieqi Zheng

    Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    6 shared publications
  • Minhu Chen

    Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    6 shared publications
  • Minhu Chen

    Department of Gastroenterology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

    5 shared publications
  • Li Li

    Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    4 shared publications

Latest Publications

  • Childhood exposure to a sibling with Crohn’s disease alters gut microbiome and Crohn’s disease susceptibility

    by Rirong Chen, Hyun Jung Kim, Maham Bushra, Cong Phi Dang, Qilong Li, Osvaldo Espin-Garcia, Hien Q Huynh, Kevan Jacobson, Alain Bitton, Remo Panaccione, et al.

    Background: Siblings of individuals with Crohn’s disease (CD) are at increased risk for developing CD but the underlying mechanisms remain unclear. Objective: We hypothesised that childhood (vs adult) exposure to a sibling with CD drives microbial perturbations, increasing CD susceptibility. Design: We used the prospective Genetic Environmental Microbial (GEM) Project and the nationwide South Korean database to assess the association between childhood exposure to affected siblings and CD onset. The association between childhood exposure and gut microbiome was evaluated in the GEM cohort. A T-cell transfer model of colitis in germ-free mice was conducted to investigate the effects of stool from childhood-exposed versus adult-exposed siblings. Finally, an integrative risk model combining faecal calprotectin (FCP) and microbial enterotypes was trained and internally validated within the GEM cohort. Results: In the GEM cohort, childhood exposure to an affected sibling was associated with a fourfold higher risk of developing CD compared with adult exposure (adjusted HR (aHR) (95% CI) 4.00 (1.83 to 8.75); p=5.3×10 −4 ), which was validated in the South Korean dataset (aHR (95%CI) 2.54 (1.70 to 3.81; p=6.0×10 −6 )). Childhood exposure was associated with reduced abundances of Lachnospira , Roseburia and Colidextribacter , reductions that mediation analysis identified as partially mediating CD risk. In vivo, transplantation of childhood exposure-associated microbiota into germ-free recipient mice exacerbated colitis and elevated mucosal interleukin-22 expression, supporting a potential mechanistic role. Our model identified siblings with elevated FCP and Blautia -enriched or Prevotella -enriched enterotypes as highest risk, with a 10-year cumulative incidence of 22.5%. Conclusion: Childhood exposure to siblings with CD is an independent risk factor of CD onset, potentially mediated by early-life microbial perturbation.

  • Open Access

    Magnetic resonance enterography for predicting poor prognosis in Crohn’s disease: a systematic review with meta-analysis

    by Yizhe Tie, Daiyue Wang, Zinan Fan, Li Li, Minhu Chen, Rirong Chen, Shenghong Zhang

    Background: Magnetic resonance enterography (MRE) is a noninvasive and radiation-free option for managing Crohn’s disease (CD), for which various predictors have been reported to show significant prognostic value. Objectives: The aim of this review was to summarize MRE predictors that indicated poor prognosis, including surgeries, complications, relapses, therapeutic escalations, and persistent pathological changes in patients with CD. Design: Systematic review with meta-analysis. Data sources and methods: Web of Science and PubMed were systematically searched for articles exploring the predictive performance of MRE in patients with luminal CD, with the latest search performed on July 21, 2025. Pooled analyses of odds ratios (OR) and hazard ratios for predicting poor prognosis were conducted using a random-effects model when available. Results: Thirty articles were included in this study. Meta-analysis identified five significant MRE predictors for predicting CD poor prognosis over 12 months, including inflammation (OR 3.40, 95% confidence interval (CI 1.96–5.89)), bowel wall thickening (OR 2.88, 95% CI (1.95–4.25)), strictures (OR 4.95, 95% CI (1.99–12.34)), edema (OR 2.67, 95% CI (1.25–5.69)), and fistula (OR 5.15, 95% CI (2.72–9.76)). Furthermore, scoring systems, such as the Magnetic Resonance Index of Activity (MaRIA) and Clermont scores, showed significant predictive values. Conclusion: MRE is effective in predicting the prognosis of patients with CD, with significant predictors including inflammation, bowel wall thickening, strictures, edema, fistula, and MaRIA score. Trial registration: The study protocol was registered in the International Prospective Register of Systematic Reviews (registration number: CRD42022365965).


  • Open Access

    Shifting burden of inflammatory bowel disease in women of childbearing age: from high-income to low-income countries (1990–2021)

    by Xiaofang Xu, Zhixi Huang, Zefeng Liu, Fujian Li, Xiaodan Zhong, Xiuxiu Yin, Jinlian Li, Rirong Chen, Shenghong Zhang

    Objectives Data on health inequalities in inflammatory bowel disease (IBD) among women of childbearing age (WCBA, 15–49 years) across different countries are lacking. We aimed to assess the global incidence, disability-adjusted life year (DALY) burden and cross-country inequalities of IBD in WCBA from 1990 to 2021. Design Observational study. Setting Data were extracted from the Global Burden of Disease Study 2021. Participants Women aged 15–49 years diagnosed with IBD. Primary and secondary outcome measures The primary outcomes were the total numbers and age-standardised rates of incidence and DALYs. Secondary outcomes included (1) temporal trends, assessed using estimated annual percentage change (EAPC); (2) periods of significant change identified through joinpoint regression analysis and (3) health inequalities by sociodemographic index (SDI), assessed using the slope index of inequality (SII) and the concentration index. Results Globally, from 1990 to 2021, the number of incident IBD cases among WCBA increased from 60 926 (95% uncertainty interval (UI) 50 342 to 74 910) to 98 975 (95% UI 80 568 to 124 089), and DALYs increased from 193 091 (95% UI 145 850 to 245 244) to 281 580 (95% UI 223 989 to 349 966). During the same period, the age-standardised incidence rate (ASIR) increased significantly (EAPC 0.22, 95% UI 0.1 to 0.34), whereas the age-standardised DALY rate (ASDR) decreased significantly (EAPC −0.28, 95% UI −0.35 to −0.21). In 2021, the highest ASIR (14.93 per 100 000, 95% UI 11.52 to 18.97) and ASDR (27.94 per 100 000, 95% UI 19.97 to 37.87) were observed in high-SDI regions. In contrast, the fastest increase in ASIR (EAPC 1.69, 95% UI 1.48 to 1.90) occurred in middle-SDI regions. High-middle-SDI regions exhibited the most pronounced decrease in ASDR (EAPC −0.8, 95% UI −0.92 to −0.67), whereas a notable upward trend in ASDR was found solely in low-SDI regions (EAPC 0.14, 95% UI 0.07 to 0.21). The SII for ASIR increased from 4.83 (95% CI 3.63 to 6.03) in 1990 to 6.26 (95% CI 4.90 to 7.63) in 2021, whereas the concentration index decreased from 0.35 (95% CI 0.25 to 0.44) to 0.24 (95% CI 0.16 to 0.33). The SII for ASDR decreased from 7.37 (95% CI 2.07 to 12.67) in 1990 to 5.97 (95% CI 1.38 to 10.56) in 2021, and the concentration index shifted from 0.13 (95% CI 0.06 to 0.2) in 1990 to −0.03 (95% CI −0.1 to 0.05) in 2021. Conclusions In 2021, the global incidence and ASDR burden remained concentrated in high-SDI countries, with significant regional disparities. From 1990 to 2021, health inequality in DALYs gradually shifted from high-income to low-income countries.


  • Open Access

    Early Improvement of Mental Health Is Associated With Long-Term Disease Remission in Ulcerative Colitis

    by Jieqi Zheng, Pinwei Huang, Ruiqi Feng, Li Li, Minhu Chen, Rirong Chen, Shenghong Zhang

    INTRODUCTION: Emerging evidence highlight the critical role of mental health in the management of ulcerative colitis (UC). We investigated the relationship between early mental health improvement and long-term disease remission. METHODS: This study used data from the SELECTION trial involving 381 patients treated with filgotinib. Mental health was assessed using the mental health subscale of the 36-item Short-Form Survey. Endoscopic, clinical, and histologic outcomes were assessed at week 58. Adjusted odds ratios (aOR) with 95% confidence intervals (95% CIs) were calculated using multivariable logistic regression. Receiver operating characteristic curves, combined with bootstrap resampling, were used to define the mental health response threshold. RESULTS: Early mental health improvements at week 10 were significantly associated with disease remission at week 58. Patients who showed a mental health response (subscale score changes of ≥7.85) exhibited greater odds of achieving endoscopic remission (aOR 2.67, 95% CI: 1.43–5.25), clinical remission (aOR 1.91, 95% CI: 1.22–2.99), histologic remission (aOR 1.98, 95% CI: 1.27–3.12), and disease clearance (aOR 3.48, 95% CI: 1.74–7.50). In addition, incorporating mental health response assessment along with clinical remission significantly enhanced outcome predictions. Specifically, individuals with only clinical remission at week 10 were approximately half as likely to reach week-58 endoscopic remission (aOR 0.45, 95% CI: 0.21–0.91) compared with those who attained both mental health response and clinical remission. DISCUSSION: Early mental health improvements independently predicted long-term disease remission. Integrating mental health assessments into ulcerative colitis management strategies may provide valuable insights beyond physical symptoms.


  • Development and Validation of a Clinical Nomogram for Predicting Surgery in Newly Diagnosed Crohn's Disease

    by Chao Li, Xi Zhang, Jie Qi Zheng, Yi Zhe Tie, Zhi Rong Zeng, Min Hu Chen, Ri Rong Chen, Sheng Hong Zhang

    Objectives: To develop a nomogram with easily available parameters to predict the risk of Crohn's disease (CD)‐related bowel resection in patients with newly diagnosed CD.Methods: We performed a retrospective cohort study by recruiting patients with newly diagnosed CD between 2005 and 2022. The patients were divided into the training and internal test sets in a 7:3 ratio. Adjusted multivariate Cox regression and least absolute shrinkage and selection operator analyses were used for feature selection. A nomogram was developed and evaluated using 10‐fold cross‐validation.Results: Altogether 490 patients were included, among whom 67 (13.7%) received CD‐related bowel resection during a median follow‐up of 45.2 months. Stricturing or penetrating behavior, perianal involvement, and higher C‐reactive protein (CRP) were independently associated with a higher risk of CD‐related bowel resection, while higher white blood cell (WBC) and lymphocyte levels and hemoglobin levels were protective factors. The nomogram including disease behavior, hemoglobin, CRP, and lymphocyte and WBC counts yielded a C‐statistic of 0.80 (95% confidence interval [CI] 0.74–0.86) in 10‐fold cross‐validation of the training set. Using the internal test set, the robust performance was verified with C‐statistic, calibration slope, and calibration‐in‐the‐large of 0.80 (95% CI 0.70–0.89), 1.10 (95% CI 0.61–1.56), and 0.28 (95% CI −0.17 to 0.67). Decision curve analyses indicated its potential clinical utility.Conclusion: The nomogram integrating disease behavior and laboratory data might be a promising approach for early risk stratification of CD‐related bowel resection, hence facilitating personalized treatment for newly diagnosed CD.


  • Serum Albumin and Its Trajectory Are Associated With Therapeutic Outcomes in Ulcerative Colitis

    by Jieqi Zheng, Xi Zhang, Liqian Zhang, Li Li, Minhu Chen, Rirong Chen, Shenghong Zhang


  • Open Access

    Developing and Externally Validating a Simple Index Based on the Nonlinear Relationship of Fecal Calprotectin and Long-Term Outcomes in Ulcerative Colitis

    by Jieqi Zheng, Danping Zheng, Zinan Fan, Li Li, Rirong Chen, Shenghong Zhang

    Background: The possible nonlinear association with therapeutic outcomes in ulcerative colitis may contribute to the inconclusive cutoff values of fecal calprotectin (FC). We aimed to explore the nonlinear association between FC levels and long-term therapeutic outcomes in patients with ulcerative colitis and establish a clinically applicable FC index. Methods: We included patients treated with vedolizumab or adalimumab from the VARSITY (n=661) and GEMINI 1 (n=620) studies as discovery and validation cohorts, respectively. The primary outcome was endoscopic remission at week 52 (Mayo Endoscopic Score 0). Restricted cubic splines were used to model nonlinearity between FC and long-term outcomes. Cutoff values were determined using piecewise regression to establish the FC index. Multivariable logistic regression and receiver operating characteristic curve analyses were performed to assess its predictive value. Results: A nonlinear approximate enantiomorphic "J-shaped" association was observed between post-induction FC levels and longterm outcomes. Cutoff values of 180, 500, and 1300 mu g/g were selected to construct the FC index; a higher index was significantly associated with a poorer outcome (P for trend <0.05). Furthermore, the FC index had an area under the receiver operating characteristic curve of 0.7095 [95% CI: 0.6621-0.7569], 0.6856 [95% CI: 0.6427-0.7284], 0.7527 [95% CI: 0.7084-0,7971], and 0.7630 [95% CI: 0.7110-0.8150] in predicting long-term endoscopic remission, clinical remission, histological remission, and disease clearance, respectively, approximately comparable to continuous FC, and superior to dichotomous FC. Conclusion: The FC index is a promising indicator of therapeutic outcomes and may guide clinicians' therapeutic decisions.


  • Open Access

    Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis

    by Jieqi Zheng, Zinan Fan, Chao Li, Daiyue Wang, Shenghong Zhang, Rirong Chen

    Objectives: Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC. Design: This is a systematic review and meta-analysis. Data sources: PubMed and Web of Science were searched up to April 2024. Eligibility criteria: Studies on the predictors of colectomy in adult patients with ASUC were eligible. Data extraction and synthesis: Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI. Results: Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I2=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I2=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I2=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I2=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I2=0.0%), extensive colitis (1.85 (1.24 to 2.78), I2=47.5%), previous steroids (1.75 (1.23 to 2.50), I2=17.7%) or azathioprine (2.25 (1.28 to 3.96), I2=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I2=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I2=1.5%) was the only predictor found to predict colectomy over 1 year. Conclusion: Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.


  • Open Access

    Serum amyloid A for predicting prognosis in patients with newly diagnosed Crohn’s disease

    by Qia Chen, Xi Zhang, Yizhe Tie, Jianwu Zhang, Pinwei Huang, Yuxuan Xie, Liqian Zhang, Xueer Tang, Zhirong Zeng, Li Li, et al.

    Objective Serum amyloid A (SAA) was found to be positively correlated with the activity of Crohn’s disease (CD); however, its prognostic value remains uncertain. Here, we examined its predictive ability in newly diagnosed CD and explored genetic association. Methods This retrospective cohort study included patients newly diagnosed as CD at the First Affiliated Hospital of Sun Yat-sen University between June 2010 and March 2022. We employed receiver operating characteristic curve, Cox proportional hazard regression models and restricted cubic splines to investigate the prognostic performance of SAA for surgery and disease progression. To assess possible causality, a two-sample Mendelian randomisation (MR) of published genome-wide association study data was conducted. Results During 2187.6 person-years (median age, 28 years, 72.4% male), 87 surgery and 153 disease progression events were documented. A 100-unit increment in SAA level generated 14% higher risk for surgery (adjusted HR (95% CI): 1.14 (1.05–1.23), p=0.001) and 12% for disease progression (1.12 (1.05–1.19), pConclusion Although causality was not found, baseline SAA level was an independent predictor of surgery and disease progression in newly diagnosed CD, and had additive benefit to existing prediction models.